Clinical Trial Update: Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of PRX003 in subjects with psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• PRX003

Snippet

Sponsor: Prothena Biosciences Limited | Conditions: Psoriasis | Phase 1 | Status: COMPLETED